featured-Reporter Archive — Page 101 of 140

Eight people pose indoors beside a Vanderbilt University banner; two people hold framed award certificates, including an Above and Beyond Award presentation. The banner reads “VANDERBILT UNIVERSITY,” “ACADEMIC EXCELLENCE,” “CLINICAL INNOVATION,” “WE ARE VANDERBILT,” and “JOIN US.”
March 19, 2015

VUMC lauded for supporting employees in National Guard

Three formally dressed instructors stand indoors in front of windows: Paul Harris on the left, Stephany Duda in the center, and Firas Wehbe on the right.
March 19, 2015

Data management MOOC educates students worldwide

Man operating a yellow patient-monitoring device beside a medical training mannequin in a clinical simulation room.
March 12, 2015

New simulation app enhances resuscitation skills training

Vanderbilt University Medical Center’s resuscitation program is taking advantage of software technology to help teach lifesaving skills to health care providers who work in critical care.

A man wearing a gray winter hat and black athletic clothing stands in front of a park bench on a hillside, with a city and mountain range visible in the background.
March 12, 2015

Laser technology offers new option to treat epilepsy

Vanderbilt University Medical Center recently debuted a new minimally invasive surgical treatment for epilepsy.

Blood clot caught on a stent-based medical retrieval device resting on white surgical gauze.
March 12, 2015

Teamwork, technology help keep Stroke Center on top

For nearly a decade, Vanderbilt University Medical Center has been at the forefront of stroke treatment using endovascular neuro-interventional techniques. Similar to procedures done for a heart attack, interventional stroke treatment employs suction and retrievers to remove blood clots.

Illustration of overlapping purple spherical cells, each with a prominent blue spherical nucleus, against a black background.
March 12, 2015

Gene mutations may predict melanoma response to immunotherapies

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators.